Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$4.16 - $9.08 $1,152 - $2,515
-277 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$7.65 - $11.38 $2,119 - $3,152
277 New
277 $2,000
Q2 2021

Aug 06, 2021

SELL
$11.87 - $15.96 $80,953 - $108,847
-6,820 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$13.87 - $21.04 $94,593 - $143,492
6,820 New
6,820 $94,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.